6-36677426-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001291549.3(CDKN1A):​c.-141-270T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 151,954 control chromosomes in the GnomAD database, including 13,635 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 13635 hom., cov: 32)

Consequence

CDKN1A
NM_001291549.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.318

Publications

39 publications found
Variant links:
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]
DINOL (HGNC:53146): (damage induced long noncoding RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.546 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1ANM_001291549.3 linkc.-141-270T>C intron_variant Intron 1 of 3 NP_001278478.1 P38936
CDKN1ANM_001374509.1 linkc.-49-362T>C intron_variant Intron 1 of 3 NP_001361438.1
CDKN1ANM_001374510.1 linkc.34+856T>C intron_variant Intron 1 of 2 NP_001361439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1AENST00000448526.6 linkc.-37-476T>C intron_variant Intron 1 of 3 3 ENSP00000409259.3 P38936
CDKN1AENST00000615513.4 linkc.-6+902T>C intron_variant Intron 1 of 2 2 ENSP00000482768.1 P38936
CDKN1AENST00000459970.1 linkn.44-362T>C intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.411
AC:
62414
AN:
151836
Hom.:
13592
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.551
Gnomad AMI
AF:
0.218
Gnomad AMR
AF:
0.362
Gnomad ASJ
AF:
0.527
Gnomad EAS
AF:
0.288
Gnomad SAS
AF:
0.373
Gnomad FIN
AF:
0.329
Gnomad MID
AF:
0.519
Gnomad NFE
AF:
0.357
Gnomad OTH
AF:
0.447
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.411
AC:
62507
AN:
151954
Hom.:
13635
Cov.:
32
AF XY:
0.409
AC XY:
30415
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.552
AC:
22853
AN:
41420
American (AMR)
AF:
0.362
AC:
5526
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.527
AC:
1828
AN:
3466
East Asian (EAS)
AF:
0.289
AC:
1493
AN:
5170
South Asian (SAS)
AF:
0.372
AC:
1796
AN:
4824
European-Finnish (FIN)
AF:
0.329
AC:
3461
AN:
10528
Middle Eastern (MID)
AF:
0.524
AC:
154
AN:
294
European-Non Finnish (NFE)
AF:
0.357
AC:
24244
AN:
67960
Other (OTH)
AF:
0.453
AC:
953
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1826
3652
5477
7303
9129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.383
Hom.:
5818
Bravo
AF:
0.419
Asia WGS
AF:
0.374
AC:
1300
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.6
DANN
Benign
0.70
PhyloP100
-0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs733590; hg19: chr6-36645203; API